Emmessar Biotech & Nutrition Limited (BOM:524768)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 28, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	148	152	148	124	137	73
Market Cap Growth	2.25%	2.25%	19.84%	-9.82%	87.08%	28.95%
Enterprise Value	79	85	90	78	94	48
Last Close Price	29.63	30.39	29.72	24.80	27.50	14.70
PE Ratio	48.57	48.03	19.81	24.59	28.90	5.07
PS Ratio	5.65	5.80	7.27	4.93	7.75	0.87
PB Ratio	1.92	1.97	2.01	1.86	2.23	1.29
P/TBV Ratio	1.92	1.97	2.01	1.86	2.23	1.29
P/FCF Ratio	-	67.84	23.04	35.41	7.00	15.76
P/OCF Ratio	66.15	67.84	23.04	32.94	6.05	15.70
EV/Sales Ratio	3.02	3.26	4.41	3.10	5.28	0.57
EV/EBITDA Ratio	7.50	8.07	21.37	9.46	16.17	2.09
EV/EBIT Ratio	8.26	8.90	27.81	10.67	19.23	2.14
EV/FCF Ratio	-	38.11	13.97	22.29	4.76	10.36
Debt / Equity Ratio	-	-	0.02	0.01	-	-
Debt / EBITDA Ratio	-	-	0.26	0.10	-	-
Debt / FCF Ratio	-	-	0.17	0.24	-	-
Asset Turnover	0.29	0.29	0.25	0.33	0.24	1.21
Inventory Turnover	1.71	1.71	1.78	4.24	2.00	5.81
Quick Ratio	15.15	15.15	12.83	12.64	14.30	3.70
Current Ratio	15.67	15.67	13.56	14.15	14.73	3.85
Return on Equity (ROE)	4.18%	4.18%	10.66%	7.85%	8.01%	29.10%
Return on Assets (ROA)	6.67%	6.67%	2.43%	6.03%	4.05%	20.22%
Return on Capital (ROIC)	7.88%	7.88%	2.84%	7.07%	5.12%	28.29%
Return on Capital Employed (ROCE)	11.00%	11.00%	3.90%	9.70%	7.10%	35.20%
Earnings Yield	2.14%	2.08%	5.05%	4.07%	3.46%	19.74%
FCF Yield	-	1.47%	4.34%	2.82%	14.30%	6.35%
Buyback Yield / Dilution	-3.72%	-3.72%	-	-	0.00%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.